Seniors

The U.S. House of Representatives voted Wednesday to enact new protections against age discrimination in the workplace, approving a bill that supporters say will give older workers the same safeguards other protected groups enjoy.

"I've heard from workers, many in the technology industry, who believe they have been dismissed or denied employment because of their age," Rep. Suzanne Bonamici, D-Beaverton, said on the House floor Wednesday.

Representative Suzanne Bonamici (D-OR) talked about House legislation designed to protect older Americans from job discrimination.

Anger against the pharmaceutical industry is growing. A Gallup poll published in September put the industry at the bottom of the heap among 25 sectors rated annually on their popularity. Nearly 60 percent of respondents said they had a negative view of the industry. People liked government more, with 52 percent seeing bureaucracies in a negative light.

Healthcare professionals, advocates, and families impacted by diabetes say the cost to treat diabetes in Oregon continues to increase.

According to a study by Quote Wizard, Oregon diabetics have the eighth highest average annual medical expenses in the nation.

Oregon Congresswoman Suzanne Bonamici says the source of the soaring prices starts with the cost of medication, Insulin in particular.

Life-sustaining medications for older Oregonians with diabetes cost federal healthcare nearly five times as they do in Australia, according to a new report done for U.S. Rep. Suzane Bonamici's office.

A dramatic rise in insulin costs over the last two decades has created a crisis in the United States, according to the report, driving people to ration out their medications, sometimes with fatal results.

Diabetes medications in Oregon costs twice as much as in Canada — and more than four times as much as in Australia — according to a new report for Congress from the House Oversight and Reform Committee. It compares the prices for 50 brand-name diabetes drugs in Oregon to those in other developed countries. It found Medicare beneficiaries in Oregon pay more than $1,000 more per year for insulin.

Diabetes medications in Oregon cost twice as much as in Canada – and more than four times as much as in Australia – according to a new report for Congress from the House Oversight and Reform Committee. It compares the prices for 50 brand-name diabetes drugs in Oregon to those in other developed countries. It found Medicare beneficiaries in Oregon pay more than $1,000 more per year for insulin.